ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Dallas, Texas. The company went IPO on 2022-11-10. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). The company is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.
최신 재무제표(Form-10K)에 따르면, ASP Isotopes Inc의 총 자산은 $0이며, 순손실입니다.
ASPI의 주요 재무 비율은 무엇인가요?
ASP Isotopes Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
ASP Isotopes Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
ASP Isotopes Inc 주요 수익원은 Specialist Isotopes and Related Services이며, 최신 수익 발표에서 수익은 3,944,226입니다. 지역별로는 United States, Guernsey, South Africa and United Kingdom이 ASP Isotopes Inc의 주요 시장이며, 수익은 4,144,225입니다.